Proteinuria News and Research

RSS
Proteinuria, also sometimes referred to as albuminuria or urine albumin, is a health condition characterized by an abnormal concentration of protein in the urine.
Pharmalink commences Nefecon Phase IIb study in primary IgA nephropathy

Pharmalink commences Nefecon Phase IIb study in primary IgA nephropathy

ETA receptor antagonism reduces novel cardiovascular risk factors in patients with CKD

ETA receptor antagonism reduces novel cardiovascular risk factors in patients with CKD

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Preeclampsia risk higher for women with Lupus

Preeclampsia risk higher for women with Lupus

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Chronic kidney disease independently increases mortality risk

Chronic kidney disease independently increases mortality risk

Complement dysregulation underpins pre-eclampsia

Complement dysregulation underpins pre-eclampsia

Absence of proteinuria good prognostic sign in IgA nephropathy

Absence of proteinuria good prognostic sign in IgA nephropathy

Anthera to initiate blisibimod Phase 3 program for systemic lupus erythematosus

Anthera to initiate blisibimod Phase 3 program for systemic lupus erythematosus

New molecular pathway that leads to preeclampsia identified

New molecular pathway that leads to preeclampsia identified

Long-term prognosis excellent for patients with IgA nephropathy

Long-term prognosis excellent for patients with IgA nephropathy

Biopsy required for accurate renal diagnosis in diabetes

Biopsy required for accurate renal diagnosis in diabetes

Rituximab aids remission in idiopathic membranous nephropathy

Rituximab aids remission in idiopathic membranous nephropathy

Questcor second quarter net sales increase to $112.5 million

Questcor second quarter net sales increase to $112.5 million

Anthera announces final set of clinical data from blisibimod Phase 2b study on SLE

Anthera announces final set of clinical data from blisibimod Phase 2b study on SLE

Chronic kidney disease is major risk factor for future coronary events

Chronic kidney disease is major risk factor for future coronary events